BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 35554594)

  • 41. Increased cerebrospinal fluid levels of nerve cell biomarkers in narcolepsy with cataplexy.
    Heier MS; Skinningsrud A; Paus E; Gautvik KM
    Sleep Med; 2014 Jun; 15(6):614-8. PubMed ID: 24784789
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hypocretin/orexin and sleep: implications for the pathophysiology and diagnosis of narcolepsy.
    Overeem S; Scammell TE; Lammers GJ
    Curr Opin Neurol; 2002 Dec; 15(6):739-45. PubMed ID: 12447114
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Validation of Multiple Sleep Latency Test for the diagnosis of pediatric narcolepsy type 1.
    Pizza F; Barateau L; Jaussent I; Vandi S; Antelmi E; Mignot E; Dauvilliers Y; Plazzi G;
    Neurology; 2019 Sep; 93(11):e1034-e1044. PubMed ID: 31405906
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Narcolepsy: a new perspective on diagnosis and treatment].
    Fronczek R; van der Zande WL; van Dijk JG; Overeem S; Lammers GJ
    Ned Tijdschr Geneeskd; 2007 Apr; 151(15):856-61. PubMed ID: 17472116
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Narcolepsy with cataplexy mimicry: the strange case of two sisters.
    Pizza F; Vandi S; Poli F; Moghadam KK; Franceschini C; Bellucci C; Cipolli C; Ingravallo F; Natalini G; Mignot E; Plazzi G
    J Clin Sleep Med; 2013 Jun; 9(6):611-2. PubMed ID: 23772196
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Relationship between clinical characteristics of narcolepsy and CSF orexin-A levels.
    Nakamura M; Kanbayashi T; Sugiura T; Inoue Y
    J Sleep Res; 2011 Mar; 20(1 Pt 1):45-9. PubMed ID: 20642748
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Narcolepsy.
    Barateau L; Pizza F; Plazzi G; Dauvilliers Y
    J Sleep Res; 2022 Aug; 31(4):e13631. PubMed ID: 35624073
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CSF hypocretin-1 levels in narcolepsy, Kleine-Levin syndrome, and other hypersomnias and neurological conditions.
    Dauvilliers Y; Baumann CR; Carlander B; Bischof M; Blatter T; Lecendreux M; Maly F; Besset A; Touchon J; Billiard M; Tafti M; Bassetti CL
    J Neurol Neurosurg Psychiatry; 2003 Dec; 74(12):1667-73. PubMed ID: 14638887
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Whole-genome analysis of monozygotic Brazilian twins discordant for type 1 narcolepsy: a case report.
    Campos JHC; Aguilar ACR; Antoneli F; Truzzi G; Briones MRS; Ferreira RC; Coelho FMS
    BMC Neurol; 2022 Nov; 22(1):439. PubMed ID: 36401198
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Monozygotic twins concordant for narcolepsy-cataplexy without any detectable abnormality in the hypocretin (orexin) pathway.
    Khatami R; Maret S; Werth E; Rétey J; Schmid D; Maly F; Tafti M; Bassetti CL
    Lancet; 2004 Apr; 363(9416):1199-200. PubMed ID: 15081654
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Narcolepsy: etiology, clinical features, diagnosis and treatment].
    Zawilska JB; Woldan-Tambor A; Płocka A; Kużajska K; Wojcieszak J
    Postepy Hig Med Dosw (Online); 2012 Oct; 66():771-86. PubMed ID: 23175331
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impaired histaminergic neurotransmission in children with narcolepsy type 1.
    Franco P; Dauvilliers Y; Inocente CO; Guyon A; Villanueva C; Raverot V; Plancoulaine S; Lin JS
    CNS Neurosci Ther; 2019 Mar; 25(3):386-395. PubMed ID: 30225986
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical, polysomnographic and genome-wide association analyses of narcolepsy with cataplexy: a European Narcolepsy Network study.
    Luca G; Haba-Rubio J; Dauvilliers Y; Lammers GJ; Overeem S; Donjacour CE; Mayer G; Javidi S; Iranzo A; Santamaria J; Peraita-Adrados R; Hor H; Kutalik Z; Plazzi G; Poli F; Pizza F; Arnulf I; Lecendreux M; Bassetti C; Mathis J; Heinzer R; Jennum P; Knudsen S; Geisler P; Wierzbicka A; Feketeova E; Pfister C; Khatami R; Baumann C; Tafti M;
    J Sleep Res; 2013 Oct; 22(5):482-95. PubMed ID: 23496005
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Rapid eye movement sleep behaviour disorder in patients with narcolepsy is associated with hypocretin-1 deficiency.
    Knudsen S; Gammeltoft S; Jennum PJ
    Brain; 2010 Feb; 133(Pt 2):568-79. PubMed ID: 20129934
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Parkinsonism with excessive daytime sleepiness--a narcolepsy-like disorder?
    Baumann C; Ferini-Strambi L; Waldvogel D; Werth E; Bassetti CL
    J Neurol; 2005 Feb; 252(2):139-45. PubMed ID: 15729517
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sex-related differences within sleep-wake dynamics, cataplexy, and EEG fast-delta power in a narcolepsy mouse model.
    Piilgaard L; Rose L; Gylling Hviid C; Kohlmeier KA; Kornum BR
    Sleep; 2022 Jul; 45(7):. PubMed ID: 35266540
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The REM-sleep-related characteristics of narcolepsy: a nation-wide multicenter study in Turkey, the REMCON study.
    Akyildiz UO; Tezer FI; Koc G; Ismailogullari S; Demir AB; Ak AK; Sunter G; Kara KA; Berktas DT; Sahin A; Azman F; Akcay BD; Gok DK; Yilmaz H; Agan K; Bekmezci Y; Yetkin S; Aksu M; Karadeniz D; Senel GB
    Sleep Med; 2022 Jun; 94():17-25. PubMed ID: 35447401
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CSF hypocretin-1 assessment in sleep and neurological disorders.
    Bourgin P; Zeitzer JM; Mignot E
    Lancet Neurol; 2008 Jul; 7(7):649-62. PubMed ID: 18565458
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hypocretin-1 Levels Associate with Fragmented Sleep in Patients with Narcolepsy Type 1.
    Alakuijala A; Sarkanen T; Partinen M
    Sleep; 2016 May; 39(5):1047-50. PubMed ID: 26856902
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Not Available].
    Monaca C; Franco P; Philip P; Dauvilliers Y
    Rev Neurol (Paris); 2017; 173(1-2):25-31. PubMed ID: 27838095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.